High-Frequency Ultrasound Imaging for Longitudinal Evaluation of Non-Alcoholic Fatty Liver Disease Progression in Mice

Ultrasound in Medicine and Biology

Volumn 37, Issue 7, 2011, Pages 1161-1169

  Fernández Domínguez, Itziar ^a   Echevarria Uraga, J Javier ^b   Gómez, Nieves ^c   Luka, Zigmund ^d   Wagner, Conrad ^d   Lu, Shelly C ^e   Mato, José M ^a   Martínez Chantar, Maria L ^a   Rodríguez Cuesta, Juan ^a  

^a CIC BIOGUNE   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Animal models; HCC; Hepatic pathology; NASH; Ultrasonography

Indexed keywords

ANIMAL MODEL; DEVELOPED COUNTRIES; HCC; HEPATIC DAMAGE; HEPATIC PATHOLOGY; HEPATOCELLULAR CARCINOMA; HIGH-FREQUENCY ULTRASOUND IMAGING; HISTOLOGICAL SECTION; HUMAN PATHOLOGIES; LIVER DISEASE; MICE MODELS; MICE STRAINS; MOUSE MODELS; NASH; NON-ALCOHOLIC FATTY LIVER DISEASE;

AMINO ACIDS; MAMMALS; PATHOLOGY; ULTRASONIC DEVICES; ULTRASONICS; ULTRASONOGRAPHY;

DISEASES;

GLYCINE N METHYTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; HEPATOGRAPHY; HIGH FREQUENCY ULTRASOUND IMAGING; HISTOPATHOLOGY; LIVER CELL CARCINOMA; MALE; MONITORING; MOUSE; MOUSE STRAIN; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; STEATOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY LIVER; MALE; MICE; MICE, INBRED STRAINS;

EID: 79959269893     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.04.012     Document Type: Article

References (32)

1. Aranha M.M., Cortez-Pinto H., Costa A., da Silva I.B., Camilo M.E., de Moura M.C., Rodrigues C.M. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol 2008, 20:519-525.
2. Bartolotta T.V., Taibbi A., Midiri M., Lagalla R. Focal liver lesions: Contrast-enhanced ultrasound. Abdom Imaging 2009, 34:193-209.
3. Coatney R.W. Ultrasound imaging: Principles and applications in rodent research. ILAR J 2001, 42:233-247.
4. Diehl A.M. Nonalcoholic steatohepatitis. Semin Liver Dis 1999, 19:221-229.
5. Diehl A.M. Lessons from animal models of NASH. Hepatol Res 2005, 33:138-144.
6. Doval D.C., Pande S.B., Sharma J.B., Pavithran K., Jena A., Vaid A.K. Prometheus' spirit: Quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy. Singapore Med J 2008, 49:e293-e295.
7. Echevarria Uraga J.J., Garcia-Alonso Montoya I., Diaz Sanz I., Herrero de la Parte B., Miguelez Vidales J.L., Zabalza Estevez I., Fernandez-Ruanova B. [Ultrasonographic characterization of an experimental model of liver metastases from colon carcinoma in rats]. Radiologia 2010, 52:37-44.
8. Directive 86/609/EEC on the approximation of laws, regulations and administrative provisions of the member states regarding the protection of animals used for experimental and other scientific purposes. Off J Eur Commun 1986, L358:1-29. European Commission.
9. Frith CH WJ. Color atlas of neoplastic and non-neoplastic lesions in aging mice. Gurnee, IL: Davis DVM Foundation, 1988.
10. Gaschen L. Update on hepatobiliary imaging. Vet Clin North Am Small Anim Pract 2009, 39:439-467.
11. Graham K.C., Wirtzfeld L.A., MacKenzie L.T., Postenka C.O., Groom A.C., MacDonald I.C., Fenster A., Lacefield J.C., Chambers A.F. Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res 2005, 65:5231-5237.
12. Hamer O.W., Aguirre D.A., Casola G., Lavine J.E., Woenckhaus M., Sirlin C.B. Fatty liver: Imaging patterns and pitfalls. Radiographics 2006, 26:1637-1653.
13. Hussain S.M., Zondervan P.E., IJzermans J.N., Schalm S.W., de Man R.A., Krestin G.P. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002, 22:1023-1036. discussion 37-39.
14. Guide for the care and use of laboratory animals 1996, Institute of Laboratory Animal Resources NRC, National Academy Press, Washington DC.
15. Jang H.J., Yu H., Kim T.K. Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging 2009, 9:96-103.
16. Jiang J., Torok N. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord 2008, 6:1-7.
17. Koteish A., Diehl A.M. Animal models of steatosis. Semin Liver Dis 2001, 21:89-104.
18. Lessa A.S., Paredes B.D., Dias J.V., Carvalho A.B., Quintanilha L.F., Takiya C.M., Tura B.R., Rezende G.F., Campos de Carvalho A.C., Resende C.M., Goldenberg R.C. Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats. BMC Vet Res 2010, 6:6.
19. Lewis J.R., Mohanty S.R. Nonalcoholic fatty liver disease: A review and update. Dig Dis Sci 2010, 55:560-578.
20. Lisi D., Kondili L.A., Ramieri M.T., Giuseppetti R., Bruni R., Della Rocca C., De Santis A., Rapicetta M. Ultrasonography in the study of hepatocellular carcinoma in woodchucks chronically infected with WHV. Lab Anim 2003, 37:233-240.
21. Lu S.C., Alvarez L., Huang Z.Z., Chen L., An W., Corrales F.J., Avila M.A., Kanel G., Mato J.M. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 2001, 98:5560-5565.
22. Mai W., Barraud L., Lefrancois L., Scoazec J.Y., Guerret S., Vray D., Merle P., Vitvitski-Trepo L., Trepo C., Janier M.F. Ultrasound detection of spontaneous hepato-cellular carcinomas in X/myc bitransgenic mice. Liver Int 2004, 24:651-657.
23. Maronpot R. Pathology of the mouse 1999, Cache River Press, Vienna, IL.
24. Martinez-Chantar M.L., Vazquez-Chantada M., Ariz U., Martinez N., Varela M., Luka Z., Capdevila A., Rodriguez J., Aransay A.M., Matthiesen R., Yang H., Calvisi D.F., Esteller M., Fraga M., Lu S.C., Wagner C., Mato J.M. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008, 47:1191-1199.
25. Martinez-Lopez N., Varela-Rey M., Ariz U., Embade N., Vazquez-Chantada M., Fernandez-Ramos D., Gomez-Santos L., Lu S.C., Mato J.M., Martinez-Chantar M.L. S-adenosylmethionine and proliferation: new pathways, new targets. Biochem Soc Trans 2008, 36:848-852.
26. Maruyama H., Ebara M. Recent applications of ultrasound: Diagnosis and treatment of hepatocellular carcinoma. Int J Clin Oncol 2006, 11:258-267.
27. Nishiura T., Watanabe H., Ito M., Matsuoka Y., Yano K., Daikoku M., Yatsuhashi H., Dohmen K., Ishibashi H. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005, 78:189-197.
28. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001, 37(Suppl 8):S4-S66.
29. Prasad S.R., Wang H., Rosas H., Menias C.O., Narra V.R., Middleton W.D., Heiken J.P. Fat-containing lesions of the liver: Radiologic-pathologic correlation. Radiographics 2005, 25:321-331.
30. Schmitz V., Tirado-Ledo L., Tiemann K., Raskopf E., Heinicke T., Ziske C., Gonzalez-Carmona M.A., Rabe C., Wernert N., Prieto J., Qian C., Sauerbruch T., Caselmann W.H. Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice. J Hepatol 2004, 40:787-791.
31. Varela-Rey M., Embade N., Ariz U., Lu S.C., Mato J.M., Martinez-Chantar M.L. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol 2009, 41:969-976.
32. Yu S.C., Yeung D.T., So N.M. Imaging features of hepatocellular carcinoma. Clin Radiol 2004, 59:145-156.